Developed in Leuven, launched at the AAOS in Las Vegas
It started two and a half years ago when a team of orthopedic surgeons went to MedEnvision asking for a medical solution. In a partnership with Comate, this triumvirate designed a patented medical device that has been launched at AAOS, the world’s largest orthopedic trade show, held in Las Vegas. A first batch of 20.000 pieces is being produced at press time.
MedEnvision starts from innovative ideas that increase efficiency in the operating theatre – thereby actively contribute to the reduction of the hospital’s Total Cost of Ownership – and turns them into sellable products.
The best ideas to increase efficiency, enhance comfort or create savings, often come from Healthcare professionals who experience inefficiencies in their daily routine. Unfortunately, these ideas mostly remain just good intentions. Developing a marketable product for medical use requires a specific expertise. The uniqueness of the MedEnvision team is that it features the various disciplines that require this expertise. From product ideation and design over clinical validation to eventually commercialization. For the solutions where expertise in mechanical engineering and design is needed, MedEnvision can count on Comate, as it was the case for the GRIPPERTM.
MedEnvision’s first development, the GRIPPERTM, is a patented self-retracting device that was originated by an unmet need. The lack of nursing staff and/or assistants forced the surgeon to search for alternatives. The GRIPPERTM is fixed on a retractor (a surgical instrument used by a surgeon to open the surgical incision or wound) and therefore replaces the nurse or assistant who usually holds the retractor in place. Many advantages arise by using the GRIPPERTM: stable and reliable s team into design outputs (drawings, components, etc.). During the creation of the output documents, risks are identified and analyzed in a failure mode and effect analysis.
There are many healthcare practitioners with brilliant ideas that need to be explored and developed. MedEnvision and Comate will continue to rely on each other's expertise and support to develop and market innovative products. Never change a winning team!